2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...
As vaccine hesitancy and misinformation continue to challenge public confidence, 1 robust real-world data are essential in sustaining trust in vaccination programs. Cai and colleagues report that ...
The Centers for Disease Control and Prevention has issued updated guidance on who should receive the 2025 COVID-19 booster, focusing on people most at risk for severe illness. Under the current ...
Real-world evidence confirms the effectiveness of the 2025-2026 formulations of mRNA-1283 and BNT162b2 against severe SARS-CoV-2 outcomes in older adults, including hospitalization and medically ...
An interim analysis published in Eurosurveillance estimates that the COVID-19 vaccine for the 2025/26 season reduced the risk of illness in Canada by about half at about 9 weeks after vaccination, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results